Modal close

Hi there,

You trust Democracy Now! to bring you the news stories and global headlines you won't find anywhere else. But did you know that Democracy Now! never accepts money from advertisers, corporate underwriters or governments? This allows us to maintain the editorial independence you rely on—but it also means we need your help. If everyone seeing this gave just $4 a month, it would more than cover our expenses for the entire year—and today a donor will DOUBLE your first month. Please do your part. It takes just a couple of minutes to make sure that Democracy Now! is there for you and everybody else. Thank you so much!
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


Sacklers Would Remain Billionaires & Admit No Wrongdoing Under Tentative Opioid Settlement

HeadlineSep 12, 2019
H6 billionaire sackler family purdue pharma opiod crisis settlement

Purdue Pharma has reached a tentative proposed settlement with a number of state, local and tribal governments over the company’s role in fueling the U.S. opioid crisis. Under emerging details of the settlement, the Sackler family, which owns Purdue, would personally pay $3 billion in cash plus another $1.5 billion after the pending sale of a subsidiary company is completed. Purdue would then declare Chapter 11 bankruptcy and dissolve, before reforming to continue selling pharmaceuticals including the opioid OxyContin. Profits would be used to pay plaintiffs. Some prosecutors have vowed to oppose the deal. Pennsylvania Attorney General Josh Shapiro said in a statement, “This apparent settlement is a slap in the face to everyone who has had to bury a loved one due to this family’s destruction and greed. It allows the Sackler family to walk away billionaires and admit no wrongdoing.”

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Up arrowTop